Shopping Cart

Your shopping cart is currently empty

TS-011

Name: TS-011
Brand: TargetMol
SKU: T13215
Price: 40 USD
Availability: InStock
Rating: 5 (10 reviews)

Copy Product Info

😃Good

Catalog No. T13215Cas No. 339071-18-0

Alias TS-011

N-(3-Chloro-4-morpholinophenyl)-N'-hydroxyformimidamide (TS-011) is a selective 20-Hydroxyeicosatetraenoic acid synthesis inhibitor.

TS-011

Copy Product Info

😃Good

Purity: 99.95%

Catalog No. T13215Alias TS-011Cas No. 339071-18-0

N-(3-Chloro-4-morpholinophenyl)-N'-hydroxyformimidamide (TS-011) is a selective 20-Hydroxyeicosatetraenoic acid synthesis inhibitor.

Pack Size	Price	USA Warehouse	Global Warehouse
5 mg	$40	-	In Stock
10 mg	$64	-	In Stock
25 mg	$106	-	In Stock
50 mg	$155	-	In Stock
100 mg	$228	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.95%

Appearance:Solid

Color:White

Resource Download

COA LCMS HNMR

Product Introduction

Bioactivity

Description	N-(3-Chloro-4-morpholinophenyl)-N'-hydroxyformimidamide (TS-011) is a selective 20-Hydroxyeicosatetraenoic acid synthesis inhibitor.
In vivo	Administered at a dose of 0.3 mg/kg, TS-011 effectively inhibits the decrease in blood flow velocities observed at 1 and 7 hours post-reperfusion, as evidenced by significant statistical values (P<0.001), and prevents the acceleration of blood flow velocity at 24 hours after reperfusion (P<0.01). Additionally, this dosage of TS-011 substantially reduces the volume of infarcts by nearly 40% (P<0.05) and maintains microvascular perfusion areas, which are otherwise diminished in mice treated with a standard vehicle [1]. Furthermore, in a study involving 9 dogs experiencing delayed vasospasm, an acute intervention with TS-011 (1 mg/kg IV) markedly enlarged the basilar artery's diameter by 39%, illustrating a significant impact on vascular health [2].
Synonyms	TS-011

Chemical Properties

Molecular Weight	255.7
Formula	C₁₁H₁₄ClN₃O₂
Cas No.	339071-18-0
Smiles	O\N=C\Nc1ccc(N2CCOCC2)c(Cl)c1
Relative Density.	1.37 g/cm3 (Predicted)

Storage & Solubility Information

Storage

In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 240 mg/mL (938.6 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (12.91 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.9108 mL	19.5542 mL	39.1083 mL	195.5417 mL
5 mM	0.7822 mL	3.9108 mL	7.8217 mL	39.1083 mL
10 mM	0.3911 mL	1.9554 mL	3.9108 mL	19.5542 mL
20 mM	0.1955 mL	0.9777 mL	1.9554 mL	9.7771 mL
50 mM	0.0782 mL	0.3911 mL	0.7822 mL	3.9108 mL
100 mM	0.0391 mL	0.1955 mL	0.3911 mL	1.9554 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc